about
RLIP76, a non-ABC transporter, and drug resistance in epilepsy.A multi-system approach assessing the interaction of anticonvulsants with P-gpEvaluation of memory enhancing clinically available standardized extract of Bacopa monniera on P-glycoprotein and cytochrome P450 3A in Sprague-Dawley ratsLack of support for a role for RLIP76 (RALBP1) in response to treatment or predisposition to epilepsy.Pharmacokinetic interactions of drugs with St John's wort.Drug-Resistant Epilepsy: Multiple Hypotheses, Few AnswersHerbal modulation of P-glycoprotein.Interactions of herbs with cytochrome P450.Genetic polymorphism of drug refractory epilepsyPotential role of drug transporters in the pathogenesis of medically intractable epilepsy.Drug resistance in epilepsy: putative neurobiologic and clinical mechanisms.Development of pharmacoresistance to benzodiazepines but not cannabinoids in the hippocampal neuronal culture model of status epilepticus.The role of common variation in drug transporter genes in refractory epilepsy.ABCB1 genotype and PGP expression, function and therapeutic drug response: a critical review and recommendations for future research.Association of carbamazepine major metabolism and transport pathway gene polymorphisms and pharmacokinetics in patients with epilepsy.Carbamazepine, but not valproate, displays pharmacoresistance in lamotrigine-resistant amygdala kindled rats.Clinical relevance of the small intestine as an organ of drug elimination: drug-fruit juice interactions.Multidrug resistance in epilepsy: a pharmacogenomic update.The emerging importance of transporter proteins in the psychopharmacological treatment of the pregnant patient.Transporter hypothesis of drug-resistant epilepsy: challenges for pharmacogenetic approaches.Association of ABCB1 gene polymorphisms and their haplotypes with response to antiepileptic drugs: a systematic review and meta-analysis.Drug resistance in epilepsy and the ABCB1 gene: The clinical perspective.Effect of Oxidative Stress on ABC Transporters: Contribution to Epilepsy Pharmacoresistance.In vitro transport profile of carbamazepine, oxcarbazepine, eslicarbazepine acetate, and their active metabolites by human P-glycoprotein.Effects of major transporter and metabolizing enzyme gene polymorphisms on carbamazepine metabolism in Chinese patients with epilepsy.The association of C3435T single-nucleotide polymorphism, Pgp-glycoprotein gene expression levels and carbamazepine maintenance dose in patients with epilepsy.The multidrug transporter hypothesis of refractory epilepsy: corroboration and contradiction in equal measure.PharmGKB summary: carbamazepine pathway.Transport of carbamazepine and drug interactions at blood-brain barrier.P-glycoprotein alters blood-brain barrier penetration of antiepileptic drugs in rats with medically intractable epilepsy.Antiepileptic drug transport--of mice and men.Use of verapamil as a potential P-glycoprotein inhibitor in a patient with refractory epilepsy.A pilot study on brain-to-plasma partition of 10,11-dyhydro-10-hydroxy-5H-dibenzo(b,f)azepine-5-carboxamide and MDR1 brain expression in epilepsy patients not responding to oxcarbazepine.The association between polymorphisms in RLIP76 and drug response in epilepsy.Pharmacoresistance in epilepsy: a pilot PET study with the P-glycoprotein substrate R-[(11)C]verapamil.Carbamazepine toxicity induced by lopinavir/ritonavir and nelfinavir.ABCB1 polymorphisms influence the response to antiepileptic drugs in Japanese epilepsy patients.Permeability of blood-brain barrier in macaque model of 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine-induced Parkinson disease.Pharmacokinetic interaction studies of fenugreek with CYP3A substrates cyclosporine and carbamazepine.Concomitant Use of Carbamazepine and Rifampin in a Patient With Mycobacterium avium Complex and Seizure Disorder.
P2860
Q24533543-E9D4E739-CAB1-43E9-B3EC-4C3329939BA1Q28533527-9CE53BC4-1D92-4503-AB85-F03CB7FB17D4Q28535796-58BD4F99-30A7-41E1-95E8-30151AE791C8Q30361123-8AE9DF69-5674-48D2-8F84-C5616D8B8275Q33204911-AD995D4E-36D1-4EC2-9963-AE779AAC216AQ33875271-DB167986-6006-4301-A6C6-8E66CA7707B2Q34312035-28DF6D13-F66D-4BF3-A71B-7407B0B3A550Q35085032-9D4F3343-CED2-4442-AF50-72329D6D4251Q35351642-3CD5BFC2-A3AC-47FD-A45F-404D0C1D92F1Q36023613-5B700572-1010-42B9-93B7-DE6D67161747Q36157234-441DF8E5-F887-444D-AA2F-D9AD6A723680Q36168793-84CD0E8C-F9B6-4D66-8ABC-E36D3548C6BEQ36192748-4A32CE43-A215-4826-8F09-C3BEE34A29F1Q36592129-731FC815-DAF9-4D03-8A30-21D0510C68FAQ36603317-5C943AD7-D2FB-4599-9A51-CF556283D44AQ36674442-23B7490C-59A7-4A71-A7BF-48639C82C0A6Q36725218-44DD7530-3D55-4FF8-8E11-E9CB76826736Q36895830-2F4FBDA8-BC88-49D1-8461-5C357BFBDAC2Q37024001-05FEC062-9210-456D-ADDA-4623F94021E7Q37806763-5F0BEC32-8759-4EBB-81E3-C03AB1679DE5Q37851513-FB600DDB-A0FD-4186-BDBF-E7B369FE9CB0Q37900131-A09C9665-A6B8-4666-AEBC-3CC05822E64CQ39164058-56E23030-EBD1-4056-B05C-F29F7F5A2C7DQ39520772-268B5548-179C-4493-9DBB-A775AF6BD217Q41704645-367772A2-D59E-437F-8581-1EA0F65B4AA5Q42150746-212327D6-9A9E-4846-A3DA-5CCC2D95D791Q42153282-DFEF0523-C8C7-4884-9B58-FC85827F6874Q42157342-DB5AD770-FC40-4CBB-9496-D542EF003DC1Q42165288-7029DC86-98A1-410C-B98F-DF2BA53D6241Q42830808-400B411F-2B7E-4739-910A-AC5A2CF77E2FQ43073437-99CD25DE-C11A-4B97-925C-E2C9A6B6423CQ45029801-1E87A2DC-1E27-4785-8D28-636B1F1F6DCCQ46725875-E657A43B-FEB0-40B0-902F-B1D00506E7D4Q46845981-A15365EF-1A43-4DBC-895F-44C867F93575Q48176609-34FD0553-6D49-450D-B0D1-FB7C4A10C06BQ48499508-4157D085-B4AA-497A-8627-1B0F01B7257CQ48510594-C037A0DC-E4EA-4558-B58F-ECA53E67B4ACQ48956010-801AD5B2-8E5D-470A-B520-6D56F9B42A29Q54500100-DDE713E2-8E30-4AD5-96E0-0083952D6DA3Q55485640-B8712E57-81E4-4CE4-8879-42FDBD9E1967
P2860
description
2001 nî lūn-bûn
@nan
2001 թուականի Ապրիլին հրատարակուած գիտական յօդուած
@hyw
2001 թվականի ապրիլին հրատարակված գիտական հոդված
@hy
2001年の論文
@ja
2001年論文
@yue
2001年論文
@zh-hant
2001年論文
@zh-hk
2001年論文
@zh-mo
2001年論文
@zh-tw
2001年论文
@wuu
name
Carbamazepine is not a substrate for P-glycoprotein
@ast
Carbamazepine is not a substrate for P-glycoprotein
@en
Carbamazepine is not a substrate for P-glycoprotein
@nl
type
label
Carbamazepine is not a substrate for P-glycoprotein
@ast
Carbamazepine is not a substrate for P-glycoprotein
@en
Carbamazepine is not a substrate for P-glycoprotein
@nl
prefLabel
Carbamazepine is not a substrate for P-glycoprotein
@ast
Carbamazepine is not a substrate for P-glycoprotein
@en
Carbamazepine is not a substrate for P-glycoprotein
@nl
P2093
P2860
P1476
Carbamazepine is not a substrate for P-glycoprotein
@en
P2093
P2860
P356
10.1046/J.1365-2125.2001.01359.X
P407
P577
2001-04-01T00:00:00Z